Quotes 5-day view Delayed Swiss Exchange
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
55.86(c)
54.98(c)
53.7(c)
51.92(c)
52.1 Last
1 214 560
1 116 131
1 405 836
1 180 799
1 298 403 Volume
-1.06% -1.58% -2.33% -3.31% +0.35% Change
Sales 2020
6 584 M - -
Net income 2020
-706 M - -
Net Debt 2020
2 986 M - -
P/E ratio 2020
-36,9x
Yield 2020
0,03%
Sales 2021
7 698 M - -
Net income 2021
47,1 M - -
Net Debt 2021
2 510 M - -
P/E ratio 2021
1 095x
Yield 2021
0,21%
Capitalization
27 498 M 27 479 M -
EV / Sales 2020
4,63x
EV / Sales 2021
3,90x
Nbr of Employees
20 000
Free-Float
99,5%
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows:
- ophthalmic surgical products and equipment (56.7%): consumables (55.2% of sales), implantable products (29%) and other products (15.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors;
-...
Notations Surperformance© of Alcon Inc.
Trading Rating : Investor Rating :
All news about ALCON INC.
News in other languages on ALCON INC.
Analyst Recommendations on ALCON INC.
Britain's mid-sized banks coping with coronavirus, but warn of pain ahead
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ALCON INC.
Short Term Mid-Term Long Term Trends Neutral Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
23
Average target price
64,58 $
Last Close Price
56,70 $
Spread / Highest target
35,4%
Spread / Average Target
13,9%
Spread / Lowest Target
-18,4%
Please enable JavaScript in your browser's settings to use dynamic charts.
1st jan. Capitalization (M$)
ALCON INC. -5.26% 27 479
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
